{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:04:27Z","timestamp":1793606667276,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00198-018-4574-x","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T21:29:55Z","timestamp":1529443795000},"page":"1987-2009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature"],"prefix":"10.1007","volume":"29","author":[{"given":"M.","family":"Chakhtoura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Ramnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Shabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Abchee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Berberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hourani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"El Hajj Fuleihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"4574_CR1","first-page":"1013","volume":"10","author":"A Giard","year":"1898","unstructured":"Giard A (1898) Sur la calcification hibernale. CR Soc Biol 10:1013\u20131015","journal-title":"CR Soc Biol"},{"issue":"2","key":"4574_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/BF00442209","volume":"147","author":"A Metzker","year":"1998","unstructured":"Metzker A, Eisenstein B, Oren J, Samuel R (1998) Tumoral calcinosis revisited\u2014common and uncommon features. Eur J Pediatr 147(2):128\u2013132","journal-title":"Eur J Pediatr"},{"issue":"7","key":"4574_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00198-008-0775-z","volume":"20","author":"CE Dumitrescu","year":"2009","unstructured":"Dumitrescu CE, Kelly MH, Khosravi A, Hart TC, Brahim J, White KE, Farrow EG, Nathan MH, Murphey MD, Collins MT (2009) A case of familial tumoral calcinosis\/hyperostosis\u2013hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. Osteoporos Int 20(7):1273\u20131278","journal-title":"Osteoporos Int"},{"issue":"5","key":"4574_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/1066896912444925","volume":"20","author":"RE Slavin","year":"2012","unstructured":"Slavin RE, Wen J, Barmada A (2012) Tumoral calcinosis\u2014a pathogenetic overview a histological and ultrastructural study with a report of two new cases, one in infancy. Int J Surg Pathol 20(5):462\u2013473","journal-title":"Int J Surg Pathol"},{"issue":"3","key":"4574_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1148\/rg.263055099","volume":"26","author":"KM Olsen","year":"2006","unstructured":"Olsen KM, Chew FS (2006) Tumoral calcinosis: pearls, polemics, and alternative possibilities 1. Radiographics 26(3):871\u2013885","journal-title":"Radiographics"},{"issue":"8","key":"4574_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00402-004-0715-0","volume":"124","author":"EP Polykandriotis","year":"2004","unstructured":"Polykandriotis EP, Beutel FK, Horch RE, Gr\u00fcnert J (2004) A case of familial tumoral calcinosis in a neonate and review of the literature. Arch Orthop Trauma Surg 124(8):563\u2013567","journal-title":"Arch Orthop Trauma Surg"},{"issue":"7","key":"4574_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/ajmg.a.32225","volume":"146(","author":"I El-Rassy","year":"2008","unstructured":"El-Rassy I, Bou-Abdallah J, Al-Ghadban S, Bitar F, Nemer G (2008) Absence of NOTCH2 and Hey2 mutations in a familial Alagille syndrome case with a novel frameshift mutation in JAG1. Am J Med Genet A 146((7):937","journal-title":"Am J Med Genet A"},{"key":"4574_CR8","unstructured":"TmP\/GFR normal ranges. Available from (accessed in December 2017): \n                    http:\/\/baspath.co.uk\/test_directory\/tindex\/TmP%20Refrange.htm"},{"issue":"3","key":"4574_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000197876","volume":"71","author":"JJ Lammoglia","year":"2009","unstructured":"Lammoglia JJ, Mericq V (2009) Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. Hormone Research in Paediatrics 71(3):178\u2013184","journal-title":"Hormone Research in Paediatrics"},{"key":"4574_CR10","unstructured":"Prediction of functional effects of human nsSNPs. Available from (accessed in December 2017): \n                    http:\/\/genetics.bwh.harvard.edu\/pph2\/"},{"issue":"10","key":"4574_CR11","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/jbmr.2870","volume":"31","author":"MS Ramnitz","year":"2016","unstructured":"Ramnitz MS, Gourh P, Goldbach-Mansky R, Wodajo F, Ichikawa S, Econs MJ, White KE, Molinolo A, Chen MY, Heller T, del Rivero J, Seo-Mayer P, Arabshahi B, Jackson MB, Hatab S, McCarthy E, Guthrie LC, Brillante BA, Gafni RI, Collins MT (2016) Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome. J Bone Miner Res 31(10):1845\u20131854","journal-title":"J Bone Miner Res"},{"issue":"2","key":"4574_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00439-005-0026-8","volume":"118","author":"I Chefetz","year":"2005","unstructured":"Chefetz I, Heller R, Galli-Tsinopoulou A, Richard G, Wollnik B, Indelman M, Koerber F, Topaz O, Bergman R, Sprecher E, Schoenau E (2005) A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification. Hum Genet 118(2):261\u2013266","journal-title":"Hum Genet"},{"issue":"3","key":"4574_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pag\u00e8s","year":"2005","unstructured":"Benet-Pag\u00e8s A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14(3):385\u2013390","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4574_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbadis.2008.09.016","volume":"1792","author":"I Chefetz","year":"2009","unstructured":"Chefetz I, Kohno K, Izumi H, Uitto J, Richard G, Sprecher E (2009) GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim Biophys Acta (BBA)-Mol Basis Dis 1792(1):61\u201367","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"issue":"9","key":"4574_CR15","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Investig 117(9):2684\u20132691","journal-title":"J Clin Investig"},{"key":"4574_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bone.2015.11.015","volume":"93","author":"SM Shawar","year":"2016","unstructured":"Shawar SM, Ramadan AR, Ali BR, Alghamdi MA, John A, Hudaib FM (2016) FGF23\u2013S129F mutant bypasses ER\/Golgi to the circulation of hyperphosphatemic familial tumoral calcinosis patients. Bone 93:187\u2013195","journal-title":"Bone"},{"issue":"5","key":"4574_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.berh.2011.10.020","volume":"25","author":"EG Farrow","year":"2011","unstructured":"Farrow EG, Imel EA, White KE (2011) Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and \u03b1Klotho). Best Pract Res Clin Rheumatol 25(5):735\u2013747","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"4574_CR18","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0022-3476(81)80013-3","volume":"99","author":"MA Mikati","year":"1981","unstructured":"Mikati MA, Melhem RE, Najjar SS (1981) The syndrome of hyperostosis and hyperphosphatemia. J Pediatr 99(6):900\u2013904","journal-title":"J Pediatr"},{"issue":"4","key":"4574_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ajmg.a.33337","volume":"152","author":"S Ichikawa","year":"2010","unstructured":"Ichikawa S, Baujat G, Seyahi A, Garoufali AG, Imel EA, Padgett LR et al (2010) Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations. Am J Med Genet A 152(4):896\u2013903","journal-title":"Am J Med Genet A"},{"issue":"1","key":"4574_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12863-014-0098-3","volume":"15","author":"S Rafaelsen","year":"2014","unstructured":"Rafaelsen S, Johansson S, R\u00e6der H, Bjerknes R (2014) Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature. BMC Genet 15(1):98","journal-title":"BMC Genet"},{"issue":"1","key":"4574_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1148\/radiology.174.1.2294551","volume":"174","author":"S Martinez","year":"1990","unstructured":"Martinez S, Vogler J 3rd, Harrelson J, Lyles K (1990) Imaging of tumoral calcinosis: new observations. Radiology 174(1):215\u2013222","journal-title":"Radiology"},{"issue":"1","key":"4574_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00256-009-0808-5","volume":"39","author":"L Joseph","year":"2010","unstructured":"Joseph L, Hing SN, Presneau N, O\u2019Donnell P, Diss T, Idowu BD, Joseph S, Flanagan AM, Delaney D (2010) Familial tumoral calcinosis and hyperostosis\u2013hyperphosphataemia syndrome are different manifestations of the same disease: novel missense mutations in GALNT3. Skelet Radiol 39(1):63\u201368","journal-title":"Skelet Radiol"},{"issue":"10","key":"4574_CR23","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1210\/jc.2005-0301","volume":"90","author":"K Araya","year":"2005","unstructured":"Araya K, Fukumoto S, Backenroth R, Takeuchi Y, Nakayama K, Ito N, Yoshii N, Yamazaki Y, Yamashita T, Silver J, Igarashi T, Fujita T (2005) A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab 90(10):5523\u20135527","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4574_CR24","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1210\/jc.2004-2238","volume":"90","author":"T Larsson","year":"2005","unstructured":"Larsson T, Yu X, Davis SI, Draman MS, Mooney SD, Cullen MJ, White KE (2005) A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab 90(4):2424\u20132427","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4574_CR25","doi-asserted-by":"publisher","first-page":"E929","DOI":"10.1152\/ajpendo.90456.2008","volume":"295","author":"HJ Garringer","year":"2008","unstructured":"Garringer HJ, Malekpour M, Esteghamat F, Mortazavi SM, Davis SI, Farrow EG et al (2008) Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab 295(4):E929\u2013EE37","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4574_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","volume":"61","author":"C Bergwitz","year":"2010","unstructured":"Bergwitz C, J\u00fcppner H (2010) Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91\u2013104","journal-title":"Annu Rev Med"},{"issue":"5","key":"4574_CR27","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2106\/JBJS.H.00783","volume":"91","author":"L Masi","year":"2009","unstructured":"Masi L, Gozzini A, Franchi A, Campanacci D, Amedei A, Falchetti A, Franceschelli F, Marcucci G, Tanini A, Capanna R, Brandi ML (2009) A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis. J Bone Joint Surg 91(5):1190\u20131198","journal-title":"J Bone Joint Surg"},{"issue":"2","key":"4574_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.gene.2014.03.052","volume":"542","author":"F Abbasi","year":"2014","unstructured":"Abbasi F, Ghafouri-Fard S, Javaheri M, Dideban A, Ebrahimi A, Ebrahim-Habibi A (2014) A new missense mutation in FGF23 gene in a male with hyperostosis\u2013hyperphosphatemia syndrome (HHS). Gene 542(2):269\u2013271","journal-title":"Gene"},{"issue":"12","key":"4574_CR29","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1093\/ndt\/gfu324","volume":"29","author":"A Shah","year":"2014","unstructured":"Shah A, Miller CJ, Nast CC, Adams MD, Truitt B, Tayek JA, Tong L, Mehtani P, Monteon F, Sedor JR, Clinkenbeard EL, White K, Mehrotra R, LaPage J, Dickson P, Adler SG, Iyengar SK (2014) Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. Nephrol Dial Transplant 29(12):2235\u20132243","journal-title":"Nephrol Dial Transplant"},{"issue":"1\u20132","key":"4574_CR30","first-page":"231","volume":"28","author":"S Ghafouri-Fard","year":"2015","unstructured":"Ghafouri-Fard S, Abbasi F, Azizi F, Javaheri M, Mehdizadeh M, Setoodeh A (2015) Hyperostosis-hyperphosphatemia syndrome (HHS): report of two cases with a recurrent mutation and review of the literature. J Pediatr Endocrinol Metab 28(1\u20132):231\u2013235","journal-title":"J Pediatr Endocrinol Metab"},{"key":"4574_CR31","doi-asserted-by":"publisher","unstructured":"Jost J, Bahans C, Courbebaisse M, Tran T-A, Linglart A, Benistan K et al (2016) Topical sodium thiosulfate: a treatment for calcifications in hyperphosphatemic familial tumoral calcinosis? J Clin Endocrinol Metab. \n                    https:\/\/doi.org\/10.1210\/jc.2016-1087","DOI":"10.1210\/jc.2016-1087"},{"issue":"6","key":"4574_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E (2004) Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36(6):579\u2013581","journal-title":"Nat Genet"},{"issue":"4","key":"4574_CR33","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1210\/jc.2004-2302","volume":"90","author":"S Ichikawa","year":"2005","unstructured":"Ichikawa S, Lyles KW, Econs MJ (2005) A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab 90(4):2420\u20132423","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4574_CR34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/jcp.2005.026369","volume":"59","author":"M Campagnoli","year":"2006","unstructured":"Campagnoli M, Pucci A, Garelli E, Carando A, Defilippi C, Lala R, Ingrosso G, Dianzani I, Forni M, Ramenghi U (2006) Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family. J Clin Pathol 59(4):440\u2013442","journal-title":"J Clin Pathol"},{"issue":"1","key":"4574_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","volume":"83","author":"Y Frishberg","year":"2005","unstructured":"Frishberg Y, Topaz O, Bergman R, Behar D, Fisher D, Gordon D, Richard G, Sprecher E (2005) Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med 83(1):33\u201338","journal-title":"J Mol Med"},{"issue":"10","key":"4574_CR36","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1210\/jc.2006-0305","volume":"91","author":"HJ Garringer","year":"2006","unstructured":"Garringer HJ, Fisher C, Larsson TE, Davis SI, Koller DL, Cullen MJ, Draman MS, Conlon N, Jain A, Fedarko NS, Dasgupta B, White KE (2006) The role of mutant UDP-N-acetyl-\u03b1-d-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J Clin Endocrinol Metab 91(10):4037\u20134042","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4574_CR37","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1210\/jc.2006-1247","volume":"91","author":"S Ichikawa","year":"2006","unstructured":"Ichikawa S, Imel EA, Sorenson AH, Severe R, Knudson P, Harris GJ, Shaker JL, Econs MJ (2006) Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene. J Clin Endocrinol Metab 91(11):4472\u20134475","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4574_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10038-006-0377-6","volume":"51","author":"P Specktor","year":"2006","unstructured":"Specktor P, Cooper JG, Indelman M, Sprecher E (2006) Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred. J Hum Genet 51(5):487\u2013490","journal-title":"J Hum Genet"},{"issue":"5","key":"4574_CR39","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s10038-007-0126-5","volume":"52","author":"AM Barbieri","year":"2007","unstructured":"Barbieri AM, Filopanti M, Bua G, Beck-Peccoz P (2007) Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis. J Hum Genet 52(5):464\u2013468","journal-title":"J Hum Genet"},{"issue":"20","key":"4574_CR40","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/ajmg.a.31947","volume":"143(","author":"HJ Garringer","year":"2007","unstructured":"Garringer HJ, Mortazavi SMJ, Esteghamat F, Malekpour M, Boztepe H, Tanakol R et al (2007) Two novel GALNT3 mutations in familial tumoral calcinosis. Am J Med Genet A 143((20):2390\u20132396","journal-title":"Am J Med Genet A"},{"issue":"5","key":"4574_CR41","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1210\/jc.2006-1825","volume":"92","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S, Guigonis V, Imel EA, Courouble M, Heissat S, Henley JD, Sorenson AH, Petit B, Lienhardt A, Econs MJ (2007) Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 92(5):1943\u20131947","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4574_CR42","first-page":"183","volume":"19","author":"A Laleye","year":"2007","unstructured":"Laleye A, Alao M, Gbessi G, Adjagba M, Marche M, Coupry I et al (2007) Tumoral calcinosis due to GALNT3 C. 516-2A> T mutation in a black African family. Genet Couns (Geneva, Switzerland) 19(2):183\u2013192","journal-title":"Genet Couns (Geneva, Switzerland)"},{"issue":"6","key":"4574_CR43","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1530\/EJE-08-0011","volume":"158","author":"H Olauson","year":"2008","unstructured":"Olauson H, Krajisnik T, Larsson C, Lindberg B, Larsson TE (2008) A novel missense mutation in GALNT3 causing hyperostosis\u2013hyperphosphataemia syndrome. Eur J Endocrinol 158(6):929\u2013934","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"4574_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/17453670902807482","volume":"80","author":"F Gok","year":"2009","unstructured":"Gok F, Chefetz I, Indelman M, Kocaoglu M, Sprecher E (2009) Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis-hyperphosphatemia syndrome. Acta Orthop 80(1):131\u2013134","journal-title":"Acta Orthop"},{"issue":"5","key":"4574_CR45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00774-011-0260-1","volume":"29","author":"A Yancovitch","year":"2011","unstructured":"Yancovitch A, Hershkovitz D, Indelman M, Galloway P, Whiteford M, Sprecher E, K\u0131l\u0131\u00e7 E (2011) Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis. J Bone Miner Metab 29(5):621\u2013625","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"4574_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3109\/03009742.2014.958100","volume":"44","author":"D Demellawy El","year":"2015","unstructured":"El Demellawy D, Chang N, de Nanassy J, Nasr A (2015) GALNT3 gene mutation-associated chronic recurrent multifocal osteomyelitis and familial hyperphosphatemic familial tumoral calcinosis. Scand J Rheumatol 44(2):170\u2013172","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"4574_CR47","doi-asserted-by":"publisher","first-page":"416","DOI":"10.12968\/denu.2012.39.6.416","volume":"39","author":"A Krstevska","year":"2011","unstructured":"Krstevska A, Gale S, Blair F (2011) Tumoral calcinosis: a dental literature review and case report. Dental Update 39(6):416\u2013418 21","journal-title":"Dental Update"},{"issue":"11","key":"4574_CR48","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1002\/art.34628","volume":"64","author":"V Ratsimbazafy","year":"2012","unstructured":"Ratsimbazafy V, Bahans C, Guigonis V (2012) Dramatic diminution of a large calcification treated with topical sodium thiosulfate. Arthritis Rheum 64(11):3826","journal-title":"Arthritis Rheum"},{"key":"4574_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.12659\/AJCR.892113","volume":"15","author":"G Favia","year":"2014","unstructured":"Favia G, Lacaita MG, Limongelli L, Tempesta A, Laforgia N, Cazzolla AP et al (2014) Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features. Am J Case Rep 15:569","journal-title":"Am J Case Rep"},{"key":"4574_CR50","doi-asserted-by":"publisher","first-page":"16038","DOI":"10.1038\/boneres.2016.38","volume":"4","author":"L Sun","year":"2016","unstructured":"Sun L, Zhao L, Du L, Zhang P, Zhang M, Li M et al (2016) Identification of two novel mutations in the GALNT3 gene in a Chinese family with hyperphosphatemic familial tumoral calcinosis. Bone Res 4:16038","journal-title":"Bone Res"},{"issue":"6","key":"4574_CR51","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.semnephrol.2014.09.005","volume":"34","author":"H Olauson","year":"2014","unstructured":"Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Torres PU, Larsson TE (2014) New insights into the FGF23-Klotho axis. Semin Nephrol 34(6):586\u2013597","journal-title":"Semin Nephrol"},{"issue":"3","key":"4574_CR52","doi-asserted-by":"publisher","first-page":"F470","DOI":"10.1152\/ajprenal.90538.2008","volume":"296","author":"MS Razzaque","year":"2009","unstructured":"Razzaque MS (2009) FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Ren Physiol 296(3):F470\u2013F4F6","journal-title":"Am J Physiol Ren Physiol"},{"issue":"12","key":"4574_CR53","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.tem.2012.07.002","volume":"23","author":"N Bhattacharyya","year":"2012","unstructured":"Bhattacharyya N, Chong WH, Gafni RI, Collins MT (2012) Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab 23(12):610\u2013618","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"4574_CR54","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1096\/fj.10-154765","volume":"24","author":"MC Hu","year":"2010","unstructured":"Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, Moe OW (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24(9):3438\u20133450","journal-title":"FASEB J"},{"issue":"5747","key":"4574_CR55","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.1114245","volume":"310","author":"Q Chang","year":"2005","unstructured":"Chang Q, Hoefs S, Van Der Kemp A, Topala C, Bindels R, Hoenderop J (2005) The \u00df-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310(5747):490\u2013493","journal-title":"Science"},{"issue":"1","key":"4574_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.arr.2008.10.002","volume":"8","author":"Y Wang","year":"2009","unstructured":"Wang Y, Sun Z (2009) Current understanding of klotho. Ageing Res Rev 8(1):43\u201351","journal-title":"Ageing Res Rev"},{"issue":"2","key":"4574_CR57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11914-015-0254-3","volume":"13","author":"LJ Folsom","year":"2015","unstructured":"Folsom LJ, Imel EA (2015) Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action. Curr Osteoporos Rep 13(2):78\u201387","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"4574_CR58","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1078\/0171-9335-00389","volume":"83","author":"U auf dem Keller","year":"2004","unstructured":"auf dem Keller U, Krampert M, K\u00fcmin A, Braun S, Werner S (2004) Keratinocyte growth factor: effects on keratinocytes and mechanisms of action. Eur J Cell Biol 83(11):607\u2013612","journal-title":"Eur J Cell Biol"},{"issue":"2","key":"4574_CR59","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1210\/jc.2004-0357","volume":"90","author":"TO Carpenter","year":"2005","unstructured":"Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R (2005) Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 90(2):1012\u20131020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4574_CR60","doi-asserted-by":"publisher","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","volume":"297","author":"J Gattineni","year":"2009","unstructured":"Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, Baum M (2009) FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Ren Physiol 297(2):F282\u2013FF91","journal-title":"Am J Physiol Ren Physiol"},{"issue":"11","key":"4574_CR61","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrendo.2009.196","volume":"5","author":"MS Razzaque","year":"2009","unstructured":"Razzaque MS (2009) The FGF23\u2013Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5(11):611\u2013619","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"4574_CR62","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117(12):4003\u20134008","journal-title":"J Clin Invest"},{"issue":"1","key":"4574_CR63","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"Krajisnik T, Bj\u00f6rklund P, Marsell R, Ljunggren \u00d6, \u00c5kerstr\u00f6m G, Jonsson KB et al (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1\u03b1-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195(1):125\u2013131","journal-title":"J Endocrinol"},{"issue":"11","key":"4574_CR64","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu M-C, Sloan A, Isakova T, Guti\u00e9rrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St. John Sutton M, Ojo A, Gadegbeku C, di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-o M, Kusek JW, Keane MG, Wolf M (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11):4393\u20134408","journal-title":"J Clin Invest"},{"issue":"8","key":"4574_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000154","volume":"4","author":"D Sitara","year":"2008","unstructured":"Sitara D, Kim S, Razzaque MS, Bergwitz C, Taguchi T, Sch\u00fcler C, Erben RG, Lanske B (2008) Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet 4(8):e1000154","journal-title":"PLoS Genet"},{"issue":"19","key":"4574_CR66","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G et al (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119(19):2545\u20132552","journal-title":"Circulation"},{"issue":"7","key":"4574_CR67","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, J+APw-ppner H, Lanske B (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23(7):421\u2013432","journal-title":"Matrix Biol"},{"issue":"6","key":"4574_CR68","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE, Maeda N (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23(6):939\u2013948","journal-title":"J Bone Miner Res"},{"issue":"8","key":"4574_CR69","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/00000478-199308000-00004","volume":"17","author":"RE Slavin","year":"1993","unstructured":"Slavin RE, Wen J, Kumar D, Evans EB (1993) Familial tumoral calcinosis: a clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis. Am J Surg Pathol 17(8):788\u2013802","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4574_CR70","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1620\/tjem.180.359","volume":"180","author":"M Hatori","year":"1996","unstructured":"Hatori M, Oomamiuda K, Kokubun S (1996) Hydroxyapatite crystals in tumoral calcinosis: a case report. Tohoku J Exp Med 180(4):359\u2013364","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"4574_CR71","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31(4):607\u2013617","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4574_CR72","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1148\/radiology.156.2.3925498","volume":"156","author":"M Senac Jr","year":"1985","unstructured":"Senac Jr M, Lee F, Gilsanz V (1985) Early costochondral calcification in adolescent hyperthyroidism. Radiology 156(2):375\u2013377","journal-title":"Radiology"},{"issue":"II","key":"4574_CR73","first-page":"69","volume":"1","author":"MA Sariyildiz","year":"2012","unstructured":"Sariyildiz MA, Batmaz I, Aydin F, Azboy I (2012) Early onset idiopathic costochondral calcification can simulate costal fracture. Int J Basic Clin Stud 1(II):69\u201374","journal-title":"Int J Basic Clin Stud"},{"issue":"3","key":"4574_CR74","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00256-013-1711-7","volume":"43","author":"WK Tsang","year":"2014","unstructured":"Tsang WK, Tam KFG (2014) A mildly painful wrist mass. Skelet Radiol 43(3):413\u2013415","journal-title":"Skelet Radiol"},{"issue":"5","key":"4574_CR75","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s002340050763","volume":"41","author":"W Adams","year":"1999","unstructured":"Adams W, Laitt R, Davies M, O\u2019Donovan D (1999) Familial tumoral calcinosis: association with cerebral and peripheral aneurysm formation. Neuroradiology 41(5):351\u2013355","journal-title":"Neuroradiology"},{"issue":"3","key":"4574_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/archopht.1996.01100130337022","volume":"114","author":"F Ghanchi","year":"1996","unstructured":"Ghanchi F, Ramsay A, Coupland S, Barr D, Lee WR (1996) Ocular tumoral calcinosis: a clinicopathologic study. Arch Ophthalmol 114(3):341\u2013345","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"4574_CR77","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.mnh.0000172723.52499.38","volume":"14","author":"CM Shanahan","year":"2005","unstructured":"Shanahan CM (2005) Vascular calcification. Curr Opin Nephrol Hypertens 14(4):361\u2013367","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"4574_CR78","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejmg.2008.05.003","volume":"51","author":"I Bailleul-Forestier","year":"2008","unstructured":"Bailleul-Forestier I, Berdal A, Vinckier F, de Ravel T, Fryns JP, Verloes A (2008) The genetic basis of inherited anomalies of the teeth. Part 2: syndromes with significant dental involvement. Eur J Med Genet 51(5):383\u2013408","journal-title":"Eur J Med Genet"},{"issue":"4","key":"4574_CR79","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ijos.2012.69","volume":"4","author":"A Rangiani","year":"2013","unstructured":"Rangiani A, Cao Z-G, Liu Y, Rodgers AV, Jiang Y, Qin C-L et al (2013) Dentin matrix protein 1 and phosphate homeostasis are critical for postnatal pulp, dentin and enamel formation. Int J Oral Sci 4(4):189\u2013195","journal-title":"Int J Oral Sci"},{"issue":"2","key":"4574_CR80","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0030-4220(94)90279-8","volume":"77","author":"G Gal","year":"1994","unstructured":"Gal G, Metzker A, Garlick J, Gold Y, Calderon S (1994) Head and neck manifestations of tumoral calcinosis. Oral Surgery, Oral Medicine, Oral Pathology 77(2):158\u2013166","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology"},{"issue":"6","key":"4574_CR81","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ajmg.a.36476","volume":"164A","author":"G Finer","year":"2014","unstructured":"Finer G, Price HE, Shore RM, White KE, Langman CB (2014) Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms. Am J Med Genet A 164A(6):1545\u20131549","journal-title":"Am J Med Genet A"},{"issue":"3","key":"4574_CR82","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/230949900901700328","volume":"17","author":"AZA Alkhooly","year":"2009","unstructured":"Alkhooly AZA (2009) Medical treatment for tumoral calcinosis with eight years of follow-up: a report of four cases. J Orthop Surg 17(3):379\u2013382","journal-title":"J Orthop Surg"},{"issue":"4","key":"4574_CR83","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1016\/S8756-3282(95)80001-8","volume":"16","author":"T Yamaguchi","year":"1995","unstructured":"Yamaguchi T, Sugimoto T, Imai Y, Fukase M, Fujita T, Chihara K (1995) Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone 16(4):S247\u2013SS50","journal-title":"Bone"},{"issue":"4","key":"4574_CR84","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1210\/jcem-50-4-648","volume":"50","author":"EG Lufkin","year":"1980","unstructured":"Lufkin EG, Wilson DM, Smith LH, Bill NJ, Deluca HF, Dousa TP et al (1980) Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide. J Clin Endocrinol Metab 50(4):648\u2013653","journal-title":"J Clin Endocrinol Metab"},{"key":"4574_CR85","first-page":"963","volume":"54","author":"J Kallmeyer","year":"1978","unstructured":"Kallmeyer J, Seimon L, MacSearraigh E (1978) The effect of thyrocalcitonin therapy and phosphate deprivation on tumoral calcinosis. S Afr Med J 54:963\u2013966","journal-title":"S Afr Med J"},{"issue":"1","key":"4574_CR86","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF03349921","volume":"12","author":"R Candrina","year":"1989","unstructured":"Candrina R, Cerudelli B, Braga V, Salvi A (1989) Effects of the acute subcutaneous administration of synthetic salmon calcitonin in tumoral calcinosis. J Endocrinol Investig 12(1):55\u201357","journal-title":"J Endocrinol Investig"},{"key":"4574_CR87","unstructured":"McGrath E, Harney F, Kinsella F (2010) Rare disease: an ocular presentation of familial tumoral calcinosis. BMJ Case Rep. 2010"},{"key":"4574_CR88","unstructured":"Phosphorus and Your CKD Diet. Available from (accessed December 2017): \n                    https:\/\/www.kidney.org\/atoz\/content\/phosphorus"},{"issue":"6","key":"4574_CR89","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1210\/en.2008-0877","volume":"150","author":"S Ichikawa","year":"2009","unstructured":"Ichikawa S, Sorenson AH, Austin AM, Mackenzie DS, Fritz TA, Moh A, Hui SL, Econs MJ (2009) Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (FGF23) concentrations and hyperphosphatemia despite increased FGF23 expression. Endocrinology 150(6):2543\u20132550","journal-title":"Endocrinology"},{"key":"4574_CR90","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.semarthrit.2017.05.013","volume":"47","author":"J Goossens","year":"2017","unstructured":"Goossens J, Courbebaisse M, Caudron E, Bahans C, Vacquerie V, Melchior J, Salle PV, Moesch C, Daudon M, Frocht V, Richette P, Ea HK, Guigonis V (2017) Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: two cases. Semin Arthritis Rheum 47:451\u2013455","journal-title":"Semin Arthritis Rheum"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4574-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4574-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4574-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T19:20:55Z","timestamp":1560972055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4574-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4574"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4574-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients and family members provided written informed consent for evaluation and mutation analysis. The evaluation and consent form were approved by the Institutional Review Board at AUB-MC.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}